Astrazeneca (AZN) Dividends Paid - Common (2009 - 2026)

Astrazeneca's Dividends Paid - Common history runs 17 years deep, the most recent figure standing at -$3.3 billion for Q1 2026.

• In Q1 2026, Dividends Paid - Common rose 1.79% year-over-year to -$3.3 billion; the TTM figure through Mar 2026 stood at $5.0 billion (up 16.59% YoY), while the FY2025 annual figure was $5.0 billion, up 7.39% from the prior year.
• Dividends Paid - Common was -$3.3 billion for Q1 2026 at Astrazeneca, down from $9.9 billion in the prior quarter.
• In the past five years, Dividends Paid - Common ranged from a high of $9.9 billion in Q4 2025 to a low of -$3.3 billion in Q1 2025.
• Historically, Dividends Paid - Common has averaged $22.8 million across 5 years, with a median of -$1.6 billion in 2024.
• The sharpest annual moves came in 2022 and 2025: Dividends Paid - Common tumbled 52.3% in 2022, then soared 41.18% in 2025.
• A 5-year view of Dividends Paid - Common shows it stood at -$3.0 billion in 2022, then soared by 99.26% to -$22.0 million in 2023, then jumped by 42168.18% to $9.3 billion in 2024, then climbed by 7.39% to $9.9 billion in 2025, then slumped by 133.07% to -$3.3 billion in 2026.
• The last three Dividends Paid - Common figures came in at -$3.3 billion (Q1 2026), $9.9 billion (Q4 2025), and -$1.6 billion (Q3 2025), per Business Quant data.